TUE, 03 NOV 2026|
[BRAND]
LATEST
Economy · Finance

A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled

CNBC · World
Published 3 Nov 2026, 8:35 pm·57 min ago·1 min read
Listen to this story
Read aloud by your device

Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.

Read the full story at CNBC · World
cnbc.com
Open ↗

Related